B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+0.15%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.03B
AUM Growth
+$3.03B
(+1.6%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
102
New
13
Increased
18
Reduced
21
Closed
19
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$77.6M |
| 2 |
Harrow
HROW
|
$30.7M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$28.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$25.6M |
| 5 |
Terns Pharmaceuticals
TERN
|
$23.6M |
Top Sells
| 1 |
Natera
NTRA
|
$35.5M |
| 2 |
Travere Therapeutics
TVTX
|
$30.6M |
| 3 |
QuidelOrtho
QDEL
|
$25.7M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$23.8M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 54.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Glaukos
GKOS
$5.5B
| $90.5M | 2.99% | 1,806,651 +144,800 | +9% | +$7.25M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $90.4M | 2.98% | 3,714,672 +373,372 | +11% | +$9.08M |
|
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $77.6M | 2.56% | +766,800 | New | +$77.6M |
|
4
Xenon Pharmaceuticals
XENE
$2.98B
| $76.5M | 2.52% | 2,137,110 +589,000 | +38% | +$21.1M |
|
5
Align Technology
ALGN
$10.3B
| $69.2M | 2.28% | 207,130 -12,800 | -6% | -$4.28M |
|
6
Biogen
BIIB
$19.4B
| $61.4M | 2.02% | 220,742 -31,800 | -13% | -$8.84M |
|
|
NVRO
7
DELISTED
NEVRO CORP.
NVRO
| $59M | 1.95% | 1,632,915 +440,617 | +37% | +$15.9M |
|
8
Intuitive Surgical
ISRG
$170B
| $57M | 1.88% | 223,120 | – | – |
|
9
iRhythm Technologies
IRTC
$5.46B
| $56.3M | 1.86% | 454,169 -43,498 | -9% | -$5.4M |
|
|
10
Natera
NTRA
$23.1B
| $54.5M | 1.8% | 982,241 -638,771 | -39% | -$35.5M |
|
|
DCPH
11
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $50.1M | 1.65% | 3,241,351 -30,162 | -0.9% | -$466K |
|
12
Vaxcyte
PCVX
$4B
| $49.5M | 1.63% | 1,319,978 -42,300 | -3% | -$1.59M |
|
13
OrthoPediatrics
KIDS
$536M
| $44.2M | 1.46% | 998,871 -45,828 | -4% | -$2.03M |
|
|
14
Day One Biopharmaceuticals
DAWN
$769M
| $42.2M | 1.39% | 3,159,895 +1,913,356 | +153% | +$25.6M |
|
|
15
Enanta Pharmaceuticals
ENTA
$180M
| $42M | 1.38% | 1,038,310 +712,472 | +219% | +$28.8M |
|
16
Amgen
AMGN
$155B
| $39M | 1.29% | 161,500 +30,400 | +23% | +$7.35M |
|
|
17
Crinetics Pharmaceuticals
CRNX
$2.92B
| $32.4M | 1.07% | 2,019,714 -1,449,960 | -42% | -$23.3M |
|
18
Outset Medical
OM
$247M
| $32.3M | 1.06% | 1,754,350 +49,798 | +3% | +$916K |
|
|
19
Harrow
HROW
$1.44B
| $30.7M | 1.01% | +1,452,538 | New | +$30.7M |
|
20
Penumbra
PEN
$10.6B
| $29.8M | 0.98% | 107,044 -55,784 | -34% | -$15.5M |
|
|
BLU
21
DELISTED
BELLUS Health Inc.
BLU
| $29.7M | 0.98% | 4,126,194 +13,700 | +0.3% | +$98.6K |
|
22
Legend Biotech
LEGN
$6.41B
| $29M | 0.96% | 601,801 -56,300 | -9% | -$2.71M |
|
|
DICE
23
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $28.2M | 0.93% | 984,800 +145,725 | +17% | +$4.18M |
|
24
Krystal Biotech
KRYS
$4.27B
| $27.9M | 0.92% | 348,036 -10,020 | -3% | -$802K |
|
25
Merus
MRUS
$4.98B
| $27.1M | 0.89% | 1,473,084 -525,000 | -26% | -$9.66M |
|